Cargando…
Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
BACKGROUND: Increased intracranial pressure (ICP) frequently complicates cryptococcal meningitis. Therapeutic lumbar punctures (LPs) have acute survival benefits in the first week, and we sought to understand the longer-term survival impact of therapeutic LPs. METHODS: We prospectively enrolled huma...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454029/ https://www.ncbi.nlm.nih.gov/pubmed/36092828 http://dx.doi.org/10.1093/ofid/ofac416 |
_version_ | 1784785263348678656 |
---|---|
author | Kagimu, Enock Engen, Nicole Ssebambulidde, Kenneth Kasibante, John Kiiza, Tadeo K Mpoza, Edward Tugume, Lillian Nuwagira, Edwin Nsangi, Laura Williams, Darlisha A Hullsiek, Kathy Huppler Boulware, David R Meya, David B Rhein, Joshua Abassi, Mahsa Musubire, Abdu K |
author_facet | Kagimu, Enock Engen, Nicole Ssebambulidde, Kenneth Kasibante, John Kiiza, Tadeo K Mpoza, Edward Tugume, Lillian Nuwagira, Edwin Nsangi, Laura Williams, Darlisha A Hullsiek, Kathy Huppler Boulware, David R Meya, David B Rhein, Joshua Abassi, Mahsa Musubire, Abdu K |
author_sort | Kagimu, Enock |
collection | PubMed |
description | BACKGROUND: Increased intracranial pressure (ICP) frequently complicates cryptococcal meningitis. Therapeutic lumbar punctures (LPs) have acute survival benefits in the first week, and we sought to understand the longer-term survival impact of therapeutic LPs. METHODS: We prospectively enrolled human immunodeficiency virus (HIV)–seropositive adults with cryptococcal meningitis from 2013 to 2017 in Uganda. We assessed the association between clinical characteristics, CSF parameters, and 14- and 30-day mortality by baseline ICP. We also assessed 30-day mortality by number of follow-up therapeutic LPs performed within 7 days. RESULTS: Our analysis included 533 participants. Participants with baseline ICP >350 mm H(2)O were more likely to have Glasgow Coma Scale (GCS) score <15 (P < .001), seizures (P < .01), and higher quantitative cryptococcal cultures (P < .001), whereas participants with ICP <200 mm H(2)O were more likely to have baseline sterile CSF cultures (P < .001) and CSF white blood cell count ≥5 cells/µL (P = .02). Thirty-day mortality was higher in participants with baseline ICP >350 mm H(2)O and ICP <200 mm H(2)O as compared with baseline ICP 200–350 mm H(2)O (hazard ratio, 1.55 [95% confidence interval, 1.10–2.19]; P = .02). Among survivors at least 7 days, the 30-day relative mortality was 50% higher among participants who did not receive any additional therapeutic LPs compared to those with ≥1 additional follow-up LP (33% vs 22%; P = .04), irrespective of baseline ICP. CONCLUSIONS: Management of increased ICP remains crucial in improving clinical outcomes in cryptococcal meningitis. Guidelines should consider an approach to therapeutic LPs that is not dictated by baseline ICP. |
format | Online Article Text |
id | pubmed-9454029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94540292022-09-09 Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? Kagimu, Enock Engen, Nicole Ssebambulidde, Kenneth Kasibante, John Kiiza, Tadeo K Mpoza, Edward Tugume, Lillian Nuwagira, Edwin Nsangi, Laura Williams, Darlisha A Hullsiek, Kathy Huppler Boulware, David R Meya, David B Rhein, Joshua Abassi, Mahsa Musubire, Abdu K Open Forum Infect Dis Major Article BACKGROUND: Increased intracranial pressure (ICP) frequently complicates cryptococcal meningitis. Therapeutic lumbar punctures (LPs) have acute survival benefits in the first week, and we sought to understand the longer-term survival impact of therapeutic LPs. METHODS: We prospectively enrolled human immunodeficiency virus (HIV)–seropositive adults with cryptococcal meningitis from 2013 to 2017 in Uganda. We assessed the association between clinical characteristics, CSF parameters, and 14- and 30-day mortality by baseline ICP. We also assessed 30-day mortality by number of follow-up therapeutic LPs performed within 7 days. RESULTS: Our analysis included 533 participants. Participants with baseline ICP >350 mm H(2)O were more likely to have Glasgow Coma Scale (GCS) score <15 (P < .001), seizures (P < .01), and higher quantitative cryptococcal cultures (P < .001), whereas participants with ICP <200 mm H(2)O were more likely to have baseline sterile CSF cultures (P < .001) and CSF white blood cell count ≥5 cells/µL (P = .02). Thirty-day mortality was higher in participants with baseline ICP >350 mm H(2)O and ICP <200 mm H(2)O as compared with baseline ICP 200–350 mm H(2)O (hazard ratio, 1.55 [95% confidence interval, 1.10–2.19]; P = .02). Among survivors at least 7 days, the 30-day relative mortality was 50% higher among participants who did not receive any additional therapeutic LPs compared to those with ≥1 additional follow-up LP (33% vs 22%; P = .04), irrespective of baseline ICP. CONCLUSIONS: Management of increased ICP remains crucial in improving clinical outcomes in cryptococcal meningitis. Guidelines should consider an approach to therapeutic LPs that is not dictated by baseline ICP. Oxford University Press 2022-08-17 /pmc/articles/PMC9454029/ /pubmed/36092828 http://dx.doi.org/10.1093/ofid/ofac416 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Kagimu, Enock Engen, Nicole Ssebambulidde, Kenneth Kasibante, John Kiiza, Tadeo K Mpoza, Edward Tugume, Lillian Nuwagira, Edwin Nsangi, Laura Williams, Darlisha A Hullsiek, Kathy Huppler Boulware, David R Meya, David B Rhein, Joshua Abassi, Mahsa Musubire, Abdu K Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? |
title | Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? |
title_full | Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? |
title_fullStr | Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? |
title_full_unstemmed | Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? |
title_short | Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? |
title_sort | therapeutic lumbar punctures in human immunodeficiency virus–associated cryptococcal meningitis: should opening pressure direct management? |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454029/ https://www.ncbi.nlm.nih.gov/pubmed/36092828 http://dx.doi.org/10.1093/ofid/ofac416 |
work_keys_str_mv | AT kagimuenock therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT engennicole therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT ssebambuliddekenneth therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT kasibantejohn therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT kiizatadeok therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT mpozaedward therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT tugumelillian therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT nuwagiraedwin therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT nsangilaura therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT williamsdarlishaa therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT hullsiekkathyhuppler therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT boulwaredavidr therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT meyadavidb therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT rheinjoshua therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT abassimahsa therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement AT musubireabduk therapeuticlumbarpuncturesinhumanimmunodeficiencyvirusassociatedcryptococcalmeningitisshouldopeningpressuredirectmanagement |